Analysen von Matthew Weston
| 26.02.24 | Merck Buy | UBS AG | |
| 06.02.24 | Novartis Buy | UBS AG | |
| 31.01.24 | Novartis Buy | UBS AG | |
| 30.01.24 | Novartis Buy | UBS AG | |
| 15.01.24 | Merck Buy | UBS AG | |
| 15.01.24 | Novartis Buy | UBS AG | |
| 07.06.22 | AstraZeneca Outperform | Credit Suisse Group | |
| 06.08.21 | Merck Outperform | Credit Suisse Group | |
|
Werbung
|
|||
| 14.12.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 06.11.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 15.05.20 | Merck Outperform | Credit Suisse Group | |
| 18.02.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 29.10.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 15.02.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 09.11.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 30.08.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 30.07.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 12.06.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 25.05.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 20.05.15 | Merck Outperform | Credit Suisse Group | |